Related references
Note: Only part of the references are listed.Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Developmental Pharmacokinetics of Lamivudine in 580 Pediatric Patients Ranging from Neonates to Adolescents
Naim Bouazza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Lamivudine for the treatment of HIV
Princy N. Kumar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software
Marc Lavielle et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Maximum likelihood estimation in nonlinear mixed effects models
E Kuhn et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2005)
Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach
GD Anderson
CLINICAL PHARMACOKINETICS (2005)
Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily
GJ Yuen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics of antiretrovirals in pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2004)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women
L Mandelbrot et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Share Paper
